Fortress Biotech FBIOP
NASDAQ FBIOP
$18.27 +0.07 (+0.38%)
At close: Aug 20, 2026 · 4:00 PM EDT

Fortress Biotech, Inc. (FBIOP) Work In Process (2022 - 2025)

Fortress Biotech (FBIOP) posted quarterly Work In Process of $435000.0 for Q1 2025, down 45.96% year-over-year from $805000.0 in Q1 2024, and up 18.53% quarter-over-quarter from $367000.0 in Q4 2024.

Fortress Biotech, Inc. (FBIOP) Work In Process (2022 - 2025) Analysis & Trends

Fortress Biotech's Work In Process history runs 4 years deep, the most recent figure standing at $435000.0 for Q1 2025.

  • In Q1 2025, Work In Process fell 45.96% year-over-year to $435000.0; the TTM figure through Mar 2025 stood at $435000.0 (down 45.96% YoY), while the FY2024 annual figure was $367000.0, down 58.48% from the prior year.
  • Work In Process for Q1 2025 stood at $435000.0, up from $367000.0 in the prior quarter.
  • The five-year high for Work In Process was $2.7 million in Q2 2022, with the low at $26000.0 in Q3 2022.
  • The 4-year median for Work In Process is $495500.0 (2022), against an average of $707416.7.
  • The sharpest annual moves came in 2023 and 2024: Work In Process jumped 1661.54% in 2023, then tumbled 70.19% in 2024.
  • Fortress Biotech's Work In Process stood at $395000.0 in 2022, then soared by 123.8% to $884000.0 in 2023, then tumbled by 58.48% to $367000.0 in 2024, then climbed by 18.53% to $435000.0 in 2025.
  • Business Quant data shows FBIOP's Work In Process at $435000.0 in Q1 2025, $367000.0 in Q4 2024, and $296000.0 in Q2 2024.

Peer Comparison

Historic Data

Download Data
DateValue
Mar 31, 2025 435,000.00
Dec 31, 2024 367,000.00
Jun 30, 2024 296,000.00
Mar 31, 2024 805,000.00
Dec 31, 2023 884,000.00
Sep 30, 2023 458,000.00
Jun 30, 2023 993,000.00
Mar 31, 2023 635,000.00
Dec 31, 2022 395,000.00
Sep 30, 2022 26,000.00
Jun 30, 2022 2.66 Mn
Mar 31, 2022 533,000.00